Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients
Breast Cancer · 2026-09 · 33 (5) · 1021-1035
DOI: 10.1007/s12282-026-01875-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer, online erschienen am 12.06.2026. Verfasst von Thomas Schaschinger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hand-, Plastic and Reconstructive Surgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Microsurgery, L…. Hauptthemen laut MEDLINE: Hypoalbuminemia, Breast Neoplasms, Mastectomy, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Hypoalbuminemia is a well-known marker of poor nutritional status and has been linked to adverse outcomes in various surgical specialties. However, its role in mastectomy remains underexplored. This study investigates the impact of hypoalbuminemia on 30-day postoperative outcomes in patients undergoing mastectomy for breast cancer.
Methods
Using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2011 to 2021, we identified 37,848 female breast cancer patients who underwent mastectomy without concurrent reconstructive procedures and had documented preoperative serum albumin levels measured within 30 days of surgery. Patients were stratified by albumin level (< 3.5 g/dL vs. ≥3.5 g/dL). Multivariate logistic regression was used to assess the association between hypoalbuminemia and postoperative 30-day outcomes. ROC analysis identified albumin thresholds predictive of complications.
Results
Among 37,848 patients, 3,210 (8.5%) were hypoalbuminemic. Hypoalbuminemia was significantly associated with higher rates of any complication (16% vs. 10%; OR 1.4, p < 0.001), surgical complications (10% vs. 5.5%; OR 1.5, p < 0.001), medical complications (0.37% vs. 0.13%; OR 1.8, p < 0.001). Similarly, readmissions were significantly more frequent in hypoalbuminemic patients (7.0% vs. 3.9%; OR 1.6, p < 0.001). The need for transfusion was over three times higher (5.0% vs. 1.4%, p < 0.001), and hypoalbuminemia was associated with longer hospital stays (2.2 vs. 1.3 days, p < 0.001). Subgroup analysis revealed that these trends persisted across both total and radical mastectomy procedures. Optimal albumin thresholds for predicting complications ranged from 3.7 to 4.1 g/dL, depending on the type of complication.
Conclusion
Preoperative hypoalbuminemia is an independent predictor of increased postoperative morbidity following mastectomy. Clinicians may consider selective albumin assessment as a pragmatic tool for identifying patients with increased physiological vulnerability who may benefit from targeted preoperative optimization strategies, rather than as a stand-alone indicator of nutritional deficiency; however, further research is needed to establish optimal testing strategies and confirm clinical benefits. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hand-, Plastic and Reconstructive Surgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Microsurgery, Ludwigshafen, Germany.
- Division of Plastic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
- Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
- Department of Plastic Surgery, Charité, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Zitieren
APA
Schaschinger, T., Niederegger, T., Diatta, F., Matar, D. Y., Dean, J., Obed, D., Grundig, H., Kern, B., Tausch, C., Bayard, S., Montagna, G., Orgill, D. P., Panayi, A. C., Hundeshagen, G., & Knoedler, S. A. (2026). Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients. Breast Cancer, 33(5), 1021-1035. https://doi.org/10.1007/s12282-026-01875-y
Vancouver
Schaschinger T, Niederegger T, Diatta F, Matar DY, Dean J, Obed D, et al. Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients. Breast Cancer. 2026;33(5):1021-1035. doi:10.1007/s12282-026-01875-y
BibTeX
@article{Schaschinger2026,
author = {Schaschinger, Thomas and Niederegger, Tobias and Diatta, Fortunay and Matar, Dany Y and Dean, Jilian and Obed, Doha and Grundig, Henriette and Kern, Barbara and Tausch, Christoph and Bayard, Solange and Montagna, Giacomo and Orgill, Dennis P and Panayi, Adriana C and Hundeshagen, Gabriel and Knoedler, Samuel A},
title = {Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients},
journal = {Breast Cancer},
year = {2026},
volume = {33},
number = {5},
pages = {1021--1035},
doi = {10.1007/s12282-026-01875-y}
}
EUVIMED